Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-FR | Version v9-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-08-17 | 2022-02-03 |
| Drug Identification Number | 00727695 | 00727695 |
| Brand name | LUPRON | LUPRON |
| Common or Proper name | Leuprolide acetate | Leuprolide acetate |
| Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
| Ingredients | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 kit (2.8mL) (5mg/mL) | 1 kit (2.8mL) (5mg/mL) |
| ATC code | L02AE | L02AE |
| ATC description | HORMONES AND RELATED AGENTS | HORMONES AND RELATED AGENTS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2022-08-31 | 2022-08-03 |
| Actual discontinuation date | 2022-08-16 | |
| Remaining supply date | 2022-08-31 | 2022-08-03 |
| Discontinuation status | Discontinued | To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | AbbVie would like to inform you that this product has now been discontinued globally across AbbVie due to a lack of demand with newer alternatives available. Please note that no other AbbVie products, other than Lupron Depot 5MG/ML (DIN #00727695) will be affected. All other formats and strengths of LUPRON (leuprolide acetate injection) will continue to be produced and commercialized both globally and in Canada. Lupron Depot is also available as a 3.75 mg (1-Month SR), 7.5 mg (1-Month SR), 11.25 mg (3-Month SR), 22.5 mg (3-Month SR) and 30 mg (4-Month SR) formulation. | AbbVie would like to inform you that this product has now been discontinued globally across AbbVie due to a lack of demand with newer alternatives available. Please note that no other AbbVie products, other than Lupron Depot 5MG/ML (DIN #00727695) will be affected. All other formats and strengths of LUPRON (leuprolide acetate injection) will continue to be produced and commercialized both globally and in Canada. Lupron Depot is also available as a 3.75 mg (1-Month SR), 7.5 mg (1-Month SR), 11.25 mg (3-Month SR), 22.5 mg (3-Month SR) and 30 mg (4-Month SR) formulation. |
| Health Canada comments |